compounded vs uncompounded semaglutide Questions about Hers & compound : r/HersWeightloss title ๐ Tirzepatide vs. Semaglutide:
Description
Current data suggest no significant increase in CA or pregnancy loss
Type 2 diabetes mellitus (DM2) affects a 13.8% of the Spanish population1 and its prevalence is expected to increase in the future.2 The presence of DM2 increases significantly the risk of cardiovascular events, chronic kidney disease (CKD), and premature death3,4 and as its prevalence increases it is expected to rise the incidence of microvascular and macrovascular complications.5 Until the last decade, the control of blood glucose, blood pressure, dyslipidemia, and the use of inhibitors of the renin-angiotensin system (iSRA) have been the only strategies available to reduce cardiovascular and renal risk in this population
Ectopic Fat10:04 - Survodutide Explained: The New Dual Agonist12:45 - Managing Side Effects & Titration Schedules15:37 - Boehringer Ingelheim & the Future of Obesity Medicine16:48 - Retatrutide: Eli Lillys New Triple Agonist18:26 - A 30-Second Guide for Doctors & Patients20:11 - Closing Thoughts & Patient Transformations
doi: 10.1002/ctm2.1750 [DOI] [PMC free article] [PubMed] [Google Scholar] 46.Anderberg RH, Richard JE, Eerola K, et al

Once-weekly semaglutide in adults with overweight or obesity (STEP 5)

Additionally, research into novel delivery technologies, such as microneedle patches and implantable devices, holds the potential to further enhance patient convenience and compliance, thereby expanding the market reach and attractiveness of GLP-1 receptor agonists